Latest News

If you are wondering whether Aiful’s current share price still offers value, you are not alone. This article focuses squarely on what that price might imply for investors. Aiful recently closed at ¥569, with returns of 1.4% over 7 days, 6.4% over 30 days, 3.8% year to date, 85.1% over 1 year and 51.9% and 128.1% over 3 and 5 years respectively. This naturally raises questions about how much of the story is already reflected in the price. Recent market attention on Aiful has been shaped by...

Senate committees preparing to vote on new U.S. digital asset market structure rules have put regulatory clarity in focus for crypto-exposed stocks, including Galaxy Digital (GLXY), especially around institutional trading and custody. See our latest analysis for Galaxy Digital. Galaxy Digital’s recent 5.22% 1 day share price return to $26.82 comes after a tougher 90 day period with a 36.02% share price decline. The 1 year and 3 year total shareholder returns of 45.76% and over 7x respectively...

In the past few days, Harrow signaled that 2025 revenue could land around US$265 million, falling short of its earlier US$270–US$280 million guidance range, as strength in Iheezo and Vevye is offset by pressure in specialty and compounded segments and one-time factors. This tension between robust growth in newer ophthalmic products and emerging headwinds in legacy segments raises fresh questions about how balanced Harrow’s revenue mix really is. Next, we’ll examine how concerns over a...

Trending interest in Intuitive Surgical (ISRG) centers on expectations that AI-enabled diagnostics and software revenue could reshape margins, with investors closely watching procedure volumes, recurring sales, and the upcoming January 22 earnings report. See our latest analysis for Intuitive Surgical. Recent trading has been choppy, with a 7 day share price return of 5.23% and a 1 day move lower. However, the 90 day share price return of 28.97% and 3 year total shareholder return of 114.66%...

Sartorius Stedim Biotech S.A.'s ( EPA:DIM ) price-to-earnings (or "P/E") ratio of 79.2x might make it look like a...

Exelixis recently released preliminary 2025 results, projecting total revenues of about US$2.32 billion and net product revenues of about US$2.12 billion, while guiding 2026 total revenues to US$2.53–2.63 billion and net product revenues to US$2.33–2.43 billion, alongside updates on its oncology pipeline and business. At the same time, Exelixis moved to expand beyond cabozantinib by advancing zanzalintinib toward a potential first commercial indication and launching a new colorectal cancer...

In early 2026, Victoria’s Secret drew heightened attention as analysts issued a wave of positive ratings following stronger-than-expected earnings and an upbeat outlook. This combination of renewed analyst confidence and improving company performance has sharpened focus on how sustainably Victoria’s Secret can execute its brand and operational transformation. With analysts turning more optimistic after the earnings surprise, we’ll now explore how this shift interacts with Victoria’s...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Recent research from Escalent reveals that while the electric vehicle (EV) industry has traditionally prioritized specifications like range and charging performance, consumer preference for design is a more significant motivator for battery electric vehicle (BEV) purchases. The study highlights that both interior and exterior vehicle design now overshadow traditional specs as primary reasons for choosing a BEV, with 71% of buyers prioritizing design in their decision-making process. Findings...

The Canadian market has started 2026 with a flurry of activity, influenced by geopolitical shifts and fresh economic data, while the Bank of Canada maintains its current interest rate stance. In this context, penny stocks—often associated with smaller or newer companies—remain a niche yet intriguing investment area. When supported by strong financial health, these stocks can offer growth opportunities at lower price points.

The Canadian market has been navigating a complex landscape in early 2026, marked by geopolitical shifts and economic data releases that have yet to significantly sway the broader economy or markets. In this environment, identifying promising small-cap stocks often involves looking for companies with strong fundamentals and resilience amidst evolving global dynamics.

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Arca Continental. de's (BMV:AC) stock is up by 6.1% over the past three months. Given its impressive performance, we...

Dubai Investments PJSC (DFM:DIC) has had a great run on the share market with its stock up by a significant 12% over...

By buying an index fund, investors can approximate the average market return. But if you pick the right individual...

Rise Consulting Group (TSE:9168) has just posted its Q3 2026 numbers, with revenue of ¥2,020 million and basic EPS of ¥10.68, giving investors another data point on how the year is shaping up. The company has seen quarterly revenue move from ¥1,901 million in Q2 2025 to ¥2,175 million in Q4 2025, then to ¥2,207 million in Q1 2026 and ¥2,154 million in Q2 2026. Basic EPS has ranged from around ¥13.32 to ¥21.24 over that stretch, setting the stage for current results to be judged against a...

BioNTech (NasdaqGS:BNTX) has laid out an expanded oncology plan for 2026, centered on a broader late-stage pipeline, additional combination studies with large partners, and more Phase 3 trial initiations and data readouts. See our latest analysis for BioNTech. The oncology update lands after a strong near term run, with a 1 day share price return of 4.90% and 30 day share price return of 13.06%. However, the 1 year total shareholder return of a 4.66% decline and 3 year total shareholder...

Earlier in January 2026, President Donald Trump called for a one-year cap on US credit card interest rates at 10%, a move that could materially reshape economics for major card issuers such as Capital One Financial by limiting interest income and potentially tightening lending standards. While framed as a way to save consumers billions of dollars in interest, the proposed cap could reduce access to traditional credit cards, push more borrowers toward alternatives such as 0% buy now, pay...

Carlisle Companies (CSL) has been drawing attention after recent share price moves, with the stock last closing at $356.42. Investors are weighing this level against the company’s latest financial profile and multi year return record. See our latest analysis for Carlisle Companies. The recent share price strength, including a 6.1% 7 day share price return and an 8.5% year to date share price return, contrasts with a 5.6% decline in 1 year total shareholder return. However, the 5 year total...

In early January 2026, Cirrus Aircraft announced its 2026 SR Series G7+ models for the SR20, SR22 and SR22T, adding upgraded avionics, expanded global connectivity, new propeller options and refreshed designs across its best-selling single-engine piston lineup. A particularly distinctive element of the launch is Cirrus Global Connect’s expanded always-on weather and communication capabilities, which deepen integration between cockpit technology and continuous global connectivity for pilots...

If you are wondering whether Unum Group stock still offers value after its recent run, this article walks through what the current price might be implying. The share price recently closed at US$79.33, with returns of 0.9% over 7 days, 2.9% over 30 days, 2.7% year to date, 11.2% over 1 year and a very large gain over 5 years. Recent commentary around Unum Group has focused on how investors are reassessing insurers in general and what that could mean for pricing power and balance sheet...

In recent months, Lam Research reported stronger-than-expected quarterly results and guidance, while analysts highlighted its leading role in supplying equipment for advanced, AI-driven semiconductor manufacturing. A key theme emerging from the latest commentary is growing confidence that Lam’s exposure to memory and wafer-fab equipment demand could keep it central to the next phase of chip-industry investment. We’ll now examine how this stronger earnings backdrop and upbeat analyst...

EMCOR Group (EME) has drawn investor attention after recent share price moves, with the stock up over the past month, slightly lower over the past 3 months, and flat over the past week. See our latest analysis for EMCOR Group. Zooming out, EMCOR Group’s 1-month share price return of 7.52% and year to date share price return of 4.99% sit alongside a very large 5-year total shareholder return. This suggests momentum has been building over the longer term, even with a softer 90-day share price...

Accenture (ACN) is back in focus for investors after recent share price moves, with the stock showing mixed returns over different periods as the market reassesses large IT services and consulting names. See our latest analysis for Accenture. Recent moves have been mixed, with a 1 day share price return of a 1.48% decline contrasting with a 90 day share price return of 15.47%. The 1 year total shareholder return of an 18.56% decline suggests momentum has been fading over a longer horizon. If...